ClinicalTrials.Veeva

Menu
V

Velocity Clinical Research | Greenville, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 456906
PLN-74809
AD504
Naltrexone Hydrochloride
Bupropion Hydrochloride
Atomoxetine Hydrochloride
Survodutide
Bexotegrast
BMS-986278

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Enrolling
Progressive Pulmonary Fibrosis
Drug: BMS-986278 Placebo
Drug: BMS-986278

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination

A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of bexotegrast (PLN-74809) for the treatment o...

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: PLN-74809
Drug: Placebo

Trial sponsors

Apnimed logo
Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
C
K
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems